Holostem is the first biotechnological company entirely devoted to development, manufacture, registration and distribution of Advanced Therapies Medicinal Products (ATMPs) based on cultures of epithelial stem cells both for cell and gene therapy.
eCRF development, data management and statistical consultancy activities related to clinical trials in the field of Rare Diseases promoted by Holostem Terapie Avanzate
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
